Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

搜集汇总

背景与挑战

背景概述

该数据集聚焦于口服减毒活人轮状病毒疫苗Rotarix在巴西儿童中的保护效果。研究表明，该疫苗能在儿童出生后头两年内，持续提供对严重G9P[8]轮状病毒胃肠炎的高度保护。